Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Amortization of Deferred Charges (2021 - 2022)

Korro Bio (KRRO) has disclosed Amortization of Deferred Charges for 2 consecutive years, with -$25000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Amortization of Deferred Charges fell 114.88% year-over-year to -$25000.0, compared with a TTM value of $396000.0 through Dec 2022, up 14.12%, and an annual FY2022 reading of $396000.0, up 14.12% over the prior year.
  • Amortization of Deferred Charges was -$25000.0 for Q4 2022 at Korro Bio, down from -$22000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $266000.0 in Q1 2022 and bottomed at -$25000.0 in Q4 2022.